Evidence-based·Last reviewed May 31, 2026·How we grade evidence

Vitamin B6 (pyridoxal 5-phosphate)

VitaminPyridoxal 5-phosphate monohydrate

P5P is the active coenzyme form of vitamin B6. For most healthy adults the liver converts ordinary pyridoxine to P5P just fine, so the marketing claim that P5P is dramatically more bioavailable is overstated. P5P matters specifically in rare PNPO deficiency, possibly in people on drugs that interfere with conversion, and as a 'gentler' option some users tolerate better.

Quick decision guide

May help most

PNPO deficiency (paediatric, prescription); adults with marginal liver function or on drugs that interfere with pyridoxine activation (isoniazid, hydralazine, theophylline); people who experience GI upset with high-dose pyridoxine and want a lower-dose active form.

Common dosing range

10–25 mg P5P per day for general supplementation. Many products dose at 50 mg, which exceeds the EFSA UL — use 10–25 mg unless a clinician has specifically advised more.

When to expect effects

Days for nausea or homocysteine; weeks for tissue B6 markers.

Watch out for

Chronic intake of any B6 form (P5P or pyridoxine) above ~50 mg/day for months risks sensory peripheral neuropathy. EFSA now caps total B6 at 12 mg/day; the US UL is 100 mg/day.

Evidence snapshot

PNPO deficiency (paediatric)Strong
Pregnancy nausea (pyridoxine)Moderate
Homocysteine lowering (with B9/B12)Moderate
Active form is 'better' for healthy adultsLow

What is it

Pyridoxal 5-phosphate (P5P) is the active coenzyme form of vitamin B6. Unlike pyridoxine, it does not require conversion by the liver before it can support cellular reactions.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if…

You or your child has a confirmed PNPO deficiency and a clinician has prescribed P5P
You're on isoniazid, hydralazine, theophylline or penicillamine — these deplete B6 and may impair its activation
You had GI upset on a high-dose pyridoxine product and want a lower-dose active form at 10–25 mg/day
You have suspected B6 deficiency (vegetarian/vegan, alcohol use, IBD, end-stage renal disease) and want a coenzyme form
You're using B6 alongside B9/B12 for homocysteine in a high-risk vascular profile

Probably skip if…

You're a healthy adult eating an omnivorous diet — a multivitamin or a few mg of pyridoxine HCl is functionally identical
You're paying a premium for a 50 mg P5P product 'because it's 5x more bioavailable' — that claim isn't well supported and 50 mg/day chronically risks neuropathy
You're taking B6 of any form to prevent colds, boost energy, or treat ADHD/autism in adults — evidence is weak
You're already taking a B-complex and adding more P6 on top without summing the total dose

Evidence at a glance

PNPO deficiency (paediatric epileptic encephalopathy)

Strong Evidence
Effect
Seizure cessation typically within 1–3 days of starting P5P; EEG normalisation follows; lifelong therapy required
Best fit
Infants and children with confirmed PNPO deficiency on genetic testing
Time
1–3 days for seizure response

Pregnancy nausea and vomiting (NVP)

Good Evidence
Effect
~30–40% reduction in nausea scores vs placebo at 30 mg/day; smaller and inconsistent effect on vomiting frequency
Best fit
First-trimester pregnant women with mild-to-moderate nausea, especially before considering doxylamine or prescription antiemetics
Time
Days (within 3–5 days of starting)

Homocysteine lowering (with B9 and B12)

Good Evidence
Effect
Homocysteine –3 to –4 µmol/L with combined B-vitamin therapy; modest stroke risk reduction in secondary prevention
Best fit
Adults with elevated homocysteine and high vascular risk (prior stroke, advanced CKD), used as part of combined B6/B9/B12 therapy under clinician guidance
Time
Weeks for homocysteine reduction; years for clinical CV event reduction (if any)

General use — 'active form is better' in healthy adults

Mixed Evidence
Effect
No clinical-endpoint benefit demonstrated over pyridoxine HCl in healthy adults
Best fit
Adults on medications that impair pyridoxine activation, or who simply prefer the active form and dose conservatively (10–25 mg/day)
Time
Not established

Evidence for 4 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

PNPO deficiency (paediatric epileptic encephalopathy)

Corrects deficiency
Strong Evidence

Pyridoxamine 5'-phosphate oxidase (PNPO) deficiency is a rare autosomal-recessive condition where the body can't convert pyridoxine to active P5P, causing intractable neonatal seizures. A 2025 systematic review of 49 reported cases found 77.6% had clinical seizure responsiveness to P5P; survival was significantly better than in untreated siblings. This is the one setting where the active form clearly matters — pyridoxine doesn't work in the ~60% of PNPO patients who are strictly P5P-responsive.

Effect size
Seizure cessation typically within 1–3 days of starting P5P; EEG normalisation follows; lifelong therapy required
Time to effect
1–3 days for seizure response
Best fit
Infants and children with confirmed PNPO deficiency on genetic testing
Less likely
Adults with epilepsy of other causes — no rationale for P5P over standard anti-seizure medications

Bottom line: The textbook case for P5P over pyridoxine. Requires specialist care; treatment is prescribed and monitored, and ~20% develop liver toxicity that needs surveillance.

SourceStolwijk et al., 2025 — Journal of Inherited Metabolic Disease

Pregnancy nausea and vomiting (NVP)

Supplement benefit
Good Evidence

Vitamin B6 reliably reduces NVP severity. The classic RCT (Vutyavanich 1995) randomized 342 women to pyridoxine 30 mg/day vs placebo and found significant reduction in nausea scores (p = 0.0008). ACOG endorses vitamin B6 alone or combined with doxylamine as Level A first-line therapy. Trials used pyridoxine HCl, not P5P, but the coenzyme form should work equivalently because the liver converts pyridoxine to P5P readily in pregnancy.

Effect size
~30–40% reduction in nausea scores vs placebo at 30 mg/day; smaller and inconsistent effect on vomiting frequency
Time to effect
Days (within 3–5 days of starting)
Best fit
First-trimester pregnant women with mild-to-moderate nausea, especially before considering doxylamine or prescription antiemetics
Less likely
Severe hyperemesis gravidarum requiring IV hydration — B6 alone is insufficient

Bottom line: First-line treatment with strong RCT support. 10–25 mg P5P per day is a reasonable substitute for pyridoxine 30 mg. No advantage to the active form here.

SourceVutyavanich et al., 1995 — American Journal of Obstetrics and GynecologyNIH Office of Dietary Supplements — Vitamin B6 — Health Professional Fact Sheet

Homocysteine lowering (with B9 and B12)

Biomarker support
Good Evidence

B6 combined with folate and B12 reliably lowers serum homocysteine. In a meta-analysis of 8 RCTs in 8,513 stroke patients, B-vitamin therapy reduced homocysteine by ~3.84 µmol/L and lowered recurrent stroke risk (RR 0.87) and combined cardiovascular events (RR 0.89). Outside of high-risk vascular patients, lowering homocysteine in healthy adults has not translated into clinical benefit in most general-population trials. The biomarker moves; whether the patient lives longer is more conditional.

Effect size
Homocysteine –3 to –4 µmol/L with combined B-vitamin therapy; modest stroke risk reduction in secondary prevention
Time to effect
Weeks for homocysteine reduction; years for clinical CV event reduction (if any)
Best fit
Adults with elevated homocysteine and high vascular risk (prior stroke, advanced CKD), used as part of combined B6/B9/B12 therapy under clinician guidance
Less likely
Healthy adults with normal homocysteine taking B6 as 'heart health insurance' — minimal benefit demonstrated

Bottom line: Use B6 + B9 + B12 together if your clinician is targeting elevated homocysteine in high vascular risk; don't expect P5P alone to lower CV risk in healthy adults.

Evidence is mixed

Earlier large RCTs (HOPE-2, VISP, NORVIT, SEARCH) found B-vitamin therapy lowered homocysteine but did not consistently reduce cardiovascular events in most populations. The stroke-specific signal is more reliable than the general CV signal.

SourceKataria et al., 2021 — Cureus (via PMC)· conflicting
SourceKataria et al., 2021 — Cureus (via PMC)

General use — 'active form is better' in healthy adults

Mechanism only
Mixed Evidence

P5P bioavailability data come mostly from small short-term studies and mechanistic reasoning. In healthy adults with normal liver function the liver converts pyridoxine to P5P within hours, and no rigorous clinical trials show that switching to the active form improves any health endpoint. The strongest argument for P5P is in narrow clinical situations: PNPO deficiency, advanced liver disease, or drugs that block conversion (isoniazid, theophylline, hydralazine, penicillamine). For everyone else, it's a price premium without a clinical premium.

Effect size
No clinical-endpoint benefit demonstrated over pyridoxine HCl in healthy adults
Time to effect
Not established
Best fit
Adults on medications that impair pyridoxine activation, or who simply prefer the active form and dose conservatively (10–25 mg/day)
Less likely
Healthy adults with normal diet and liver function — pyridoxine HCl from a standard multivitamin is functionally equivalent

Bottom line: The marketing case is much stronger than the clinical case. If you tolerate pyridoxine fine, don't pay 3–5x for P5P expecting more benefit.

SourceNIH Office of Dietary Supplements — Vitamin B6 — Health Professional Fact Sheet

How it works

P5P serves as the cofactor for more than 100 enzymes involved in amino acid metabolism, neurotransmitter synthesis (serotonin, dopamine, GABA), hemoglobin formation, and gluconeogenesis. The body normally converts pyridoxine from food or supplements into P5P in the liver, so P5P supplements skip that step. Whether oral P5P offers a real advantage is debated. Some evidence suggests it is absorbed and used similarly to pyridoxine, since intestinal enzymes dephosphorylate P5P before absorption and re-phosphorylation occurs in the body anyway.

How to take it

1. Typical dose
• 10–25 mg P5P per day for general supplementation • Keep total B6 (P5P + pyridoxine from food/multivitamins) under ~25 mg/day for daily long-term use • PNPO deficiency dosing is set by a specialist (typically 30–50 mg/kg/day in infants) — do not extrapolate
2. Higher studied dose
Up to 50–100 mg/day is used short-term in some studies and for treating drug-induced B6 deficiency (isoniazid, hydralazine). Chronic intake above 50 mg/day carries clear peripheral neuropathy risk.
3. Timing
Take with a meal — minimises any GI upset. No clinical reason to split or time around other supplements except: separate from levodopa by at least 2 hours (B6 increases peripheral levodopa breakdown unless taken with carbidopa).
4. With food
With food.
5. Split dosing
Single daily dose at 10–25 mg is fine. Split only if you're on a higher therapeutic dose (>30 mg/day) for a specific indication.
6. How long to try
4–8 weeks to assess effect on nausea, homocysteine, or B6 deficiency markers. Long-term use is reasonable at ≤25 mg/day for at-risk populations; reassess annually with a clinician.

What to track

Nausea severity if treating NVP
Serum homocysteine if treating hyperhomocysteinemia (recheck at 8–12 weeks)
Tingling/numbness in feet or hands — early sign of sensory neuropathy, stop and see a clinician
Total B6 intake from ALL sources including multivitamins, B-complex products, energy drinks, fortified cereals

Bottom line: Take 10–25 mg with food. Sum your total B6 from all products — many multis have 25–50 mg already. The EFSA neuropathy threshold is much lower than people realise.

4 commercial forms

Compare the main delivery options and what they’re best suited for.

Pyridoxal 5'-phosphate (P5P / PLP)

Active coenzyme form

The biologically active form that all B6 ultimately becomes. Bypasses the liver activation step. Genuinely useful in PNPO deficiency and possibly in advanced liver disease or with drugs that block conversion. For healthy adults, the bioavailability advantage is small.

Direct cofactor; conversion-step bypass.

Pyridoxine HCl

Most studied

The standard supplemental form used in nearly all RCTs (including the NVP and homocysteine trials). Liver converts it to P5P within hours. Inexpensive; the form your multivitamin almost certainly contains.

≈71% oral bioavailability; reliable conversion in healthy liver.

Pyridoxamine

Niche

Another natural B6 form; FDA classified high-dose pyridoxamine as a drug after a 2009 review (it had been studied for diabetic nephropathy). Rare in supplements now; not interchangeable with consumer P5P.

Restricted in US dietary supplements since 2009.

Pyridoxal

Intermediate

The non-phosphorylated form of P5P. Phosphorylated to P5P by intestinal/hepatic enzymes. Uncommon as a standalone supplement.

Rapidly phosphorylated to P5P after absorption.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

nausea (uncommon)mild GI upsetheadache (rare)

Serious risks

Who should avoid it

Pregnancy & breastfeeding

Pyridoxine 30 mg/day is ACOG-endorsed Level A first-line therapy for pregnancy nausea, and pregnancy RDA is 1.9 mg/day with US UL 100 mg/day. P5P at equivalent doses (10–25 mg/day) is presumed comparably safe but lacks dedicated pregnancy RCTs. Use the lowest effective dose; consult your obstetrician.

SourceNIH Office of Dietary Supplements — Vitamin B6 — Health Professional Fact Sheet

Bottom line: Safe at 10–25 mg/day for the vast majority. The neuropathy story is real and dose-dependent — sum all sources of B6 and don't sit at 50–100 mg/day chronically without a clinician's reason.

Interactions

levodopa (without carbidopa)Major

B6 is a cofactor for the enzyme that decarboxylates levodopa peripherally, reducing the drug's ability to cross into the brain. Carbidopa (in Sinemet) blocks this. If you're on plain levodopa, avoid supplemental B6 entirely.

SourceNIH Office of Dietary Supplements — Vitamin B6 — Health Professional Fact Sheet
isoniazid (anti-tuberculosis)Moderate

Isoniazid binds B6 and causes deficiency-related peripheral neuropathy. Prophylactic B6 is routinely co-prescribed — typically 25–50 mg/day of pyridoxine or P5P, on TB-specialist guidance.

SourceNIH Office of Dietary Supplements — Vitamin B6 — Health Professional Fact Sheet
hydralazine, theophylline, penicillamine, cycloserineModerate

All can impair B6 activation or cause B6 depletion. Long-term users may benefit from 10–25 mg/day P5P; coordinate with the prescriber.

SourceNIH Office of Dietary Supplements — Vitamin B6 — Health Professional Fact Sheet
altretamine (cancer chemo)Moderate

High-dose B6 may reduce altretamine efficacy. Don't combine without oncology input.

SourceNIH Office of Dietary Supplements — Vitamin B6 — Health Professional Fact Sheet
anticonvulsants (phenytoin, phenobarbital, valproate)Minor

Can lower B6 levels modestly over months. High-dose B6 may also reduce anticonvulsant levels in some reports — keep B6 at standard supplemental doses and notify the neurologist.

SourceNIH Office of Dietary Supplements — Vitamin B6 — Health Professional Fact Sheet

Protocols featuring Vitamin B6 (pyridoxal 5-phosphate)

Evidence-backed routines where Vitamin B6 (pyridoxal 5-phosphate) plays a role.

Trimester 1 Prenatal

maternal

The first trimester is the highest-stakes window of pregnancy nutritionally. Neural tube formation completes by week 4-6 (often before pregnancy is even known), organogenesis is in full swing, and the most common early-pregnancy symptom — morning sickness — affects 70-85% of pregnancies. This protocol covers the four nutritional priorities for trimester 1: a methylfolate-containing prenatal (the single most-evidenced intervention in obstetric nutrition for preventing neural tube defects), vitamin B6 + ginger for nausea (both ACOG-supported as first-line), choline for fetal brain and liver development (commonly under-consumed), and iron when ferritin is confirmed low. This protocol replaces your Fertility Prep — Women stack once pregnancy is confirmed. Many supplements that were fine pre-conception (ashwagandha, vitex, berberine, high-dose vitamin A, certain herbal blends) are contraindicated in pregnancy. Coordinate every supplement with your OB.

PMS Support

hormones

Premenstrual syndrome affects up to 75% of menstruating women in some form. The supplement literature is unusually solid here — magnesium, B6, calcium, and chasteberry each have multiple randomized trials supporting their use for the physical and emotional symptoms of PMS. Effect sizes are real but modest, and the stack works best when taken consistently across the cycle rather than only in the luteal phase. Severe PMS or PMDD warrants a conversation with your doctor — supplements are first-line for mild-to-moderate symptoms, not a substitute for proper care in severe cases.

Food sources

Chickpeas, canned, ½ cup

Amount
½ cup (1.1 mg)
%DV
65%

Beef liver, pan fried

Amount
3 oz (0.9 mg)
%DV
53%

Tuna, yellowfin, cooked

Amount
3 oz (0.9 mg)
%DV
53%

Salmon, sockeye, cooked

Amount
3 oz (0.6 mg)
%DV
35%

Chicken breast, roasted

Amount
3 oz (0.5 mg)
%DV
29%

Potatoes, boiled with skin

Amount
1 cup (0.4 mg)
%DV
25%

Banana, medium

Amount
1 medium (0.4 mg)
%DV
25%

Fortified breakfast cereal

Amount
1 serving (~0.5 mg)
%DV
29%

Ground beef, 85% lean, broiled

Amount
3 oz (0.3 mg)
%DV
18%

Winter squash, cooked

Amount
½ cup (0.2 mg)
%DV
12%

Rice, white, cooked

Amount
1 cup (0.1 mg)
%DV
6%

Choosing a product

What to look for on the label — and what to be skeptical of.

Look for…

10–25 mg P5P per capsule — the safest practical daily dose given the EFSA UL
Single-ingredient capsule if you want to control total B6 intake precisely
Third-party tested (USP, NSF, ConsumerLab) — confirms the label dose
Bottle states 'pyridoxal 5-phosphate' or 'P5P' specifically (not just 'B6')
If you're treating PNPO deficiency, use a pharmaceutical-grade product — supplement-grade P5P has dose variability the literature has flagged

Be skeptical of…

'5–10x more bioavailable than pyridoxine' — small bioavailability differences, no clinical-endpoint advantage in healthy adults
'P5P is safer than pyridoxine — no neuropathy risk' — false; both forms cause neuropathy at high chronic doses
50 or 100 mg per capsule marketed for daily long-term use — exceeds the EFSA UL of 12 mg/day
'Treats ADHD / autism / anxiety / depression' marketing — evidence is thin for B6 alone in any of these in adults
Combo 'energy' or B-complex products that don't disclose the per-serving P5P content

Frequently asked questions

Is P5P actually better than pyridoxine?⌄

For most healthy people, no consistent clinical advantage has been demonstrated. P5P may be preferable in liver dysfunction or for people who prefer the active form.

Is P5P safer than pyridoxine?⌄

Both share the same upper limit (100 mg per day) and the same neuropathy risk at high chronic doses. Neither is meaningfully safer.

How much P5P should I take?⌄

Typical supplements provide 20 to 50 mg. Stay well under the 100 mg per day upper limit for total B6 from all sources.

Can I take P5P long-term?⌄

Yes, at low doses. Avoid prolonged use above 100 mg per day to prevent nerve damage.

References by claim

Pregnancy nausea and vomiting (NVP)

NIH Office of Dietary Supplements — Vitamin B6 — Health Professional Fact Sheet (2024) link

Vutyavanich et al., 1995 — American Journal of Obstetrics and Gynecology (1995) link

PNPO deficiency (paediatric epileptic encephalopathy)

Stolwijk et al., 2025 — Journal of Inherited Metabolic Disease (2025) link

Homocysteine lowering (with B9 and B12)

Kataria et al., 2021 — Cureus (via PMC) (2021) link

Safety

EFSA Panel on Nutrition, 2023 — EFSA Journal — Scientific Opinion on the tolerable upper intake level for vitamin B6 (2023) link

Other references

Vitamin B6 (pyridoxal 5-phosphate) on Wikidata — Wikidata link

Pyridoxal 5'-phosphate (ChEBI:18405) — ChEBI link

Pyridoxal 5'-Phosphate on NIH DSLD — NIH Dietary Supplement Label Database link

Track Vitamin B6 (pyridoxal 5-phosphate) with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store
Evidence-based·Last reviewed May 31, 2026·Evidence current as of May 31, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.